Pharmacy Association of Nova Scotia: Optimizing Care for Anxiety, ADHD and Depression
Discover how to effectively help patients with ADHD, depression, and anxiety.
One of the significant impacts of the COVID-19 pandemic is that many individuals are facing mental health challenges. There has been an increasing demand for mental health resources from patients. With the prevalence and rise of incidents of mental illness, such as depression and anxiety, pharmacists need to understand the signs and symptoms of mental illness and learn how to help patients in distress.
This course was developed to meet these learning needs. It will review three mental illnesses (ADHD, anxiety, and depression), and take a practical approach to study them through common cases that you would encounter in routine pharmacy practice. The course explores patients’ experiences and how to optimize care, while examining cases that are grounded in therapeutic knowledge.
By the end of this course, you should be able to:
- Identify and resolve common drug therapy problems for individuals with attention deficit hyperactivity disorder (ADHD), generalized anxiety disorder (GAD), and major depressive disorder (MDD)
- Develop pharmaceutical care plans/recommendations to solve drug therapy problems for individuals with ADHD, GAD, and MDD
- Create monitoring and follow-up plans
Course at a glance:
Who should take this course:
This course provides pharmacists with useful information they can apply to their everyday practice, especially those who have seen an increase in demand for mental health resources from their patients.